Member access

4-Traders Homepage  >  Shares  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX   US45822R1014

 SummaryNewsCalendarCompanyFinancialsRevisions 
Company
IntelGenx Technologies Corp. operates as a drug delivery company.It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies.The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
04/01Earnings Release
More about the company
Financials ($)
Sales 2011 6,00 M
EBIT 2011 -0,10 M
Net income 2011 -0,10 M
Debt 2011 -
Yield 2011 -
Sales 2012 0,97 M
EBIT 2012 -1,88 M
Net income 2012 -2,14 M
Debt 2012 -
Yield 2012 -
PER 2011 41,88
PER 2012
Capi. / Sales 2011 8,86x
Capi. / Sales 2012 55,0x
Capitalization 53,2 M
More Financials
Latest news on INTELGENX TECHNOLOGIES COR
02/25 INTELGENX TECHNOLOGIES : Provides Update on Sales of Forfivo XL
02/23 INTELGENX TECHNOLOGIES : 2015-02-23 IntelGenx Provides Update on Sales of Forfiv..
02/23 IntelGenx Provides Update on Sales of Forfivo XL(R)
02/23 INTELGENX TECHNOLOGIES : Provides Update on Sales of Forfivo XL(R)
01/12 INTELGENX TECHNOLOGIES : 2015-01-05 IntelGenx to Present at the 8th Annual OneMe..
01/05 IntelGenx to Present at the 8th Annual OneMedForum
01/05 IntelGenx to Present at the 8th Annual OneMedForum
2014 IntelGenx Grants Stock Options
More news
Sector news Generic Pharmaceuticals
08:40p JOHNSON & JOHNSON : Announces Binding Offer from Cardinal Health to Acquire Cord..
07:31p ACTAVIS : Announces Pricing of Public Offering of Senior Notes in Connection wit..
05:52pDJFDA Warns on Low-Testosterone Drugs -- Update
Plus d'actualités du secteur Generic Pharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF